ABSTRACT. A two-year-old dog having presented with neurological signs showed marked leukocytosis and appearance of blast cells in the peripheral blood. Hematological and bone marrow examination showed an increase in blasts having both myeloid and monocytic cells characteristics. The dog was diagnosed with acute myelomonocytic leukemia (AML-M4) on the basis of bone marrow findings. Although the dog was treated with a multi-combination chemotherapy, the neurological abnormalities progressed and the dog was euthanized. Myelographic examination and necropsy revealed the extradural lesion formed by AML-M4 around the cervical spinal cord and this lesion was considered as a cause of the neurological signs.
Acute myeloid leukemia (AML) is a disorder in which bone marrow hematopoietic cells show neoplastic proliferation. The disease is classified into subtypes on the basis of the origins and degrees of differentiation of blast cells in blood and/or bone marrow.
Acute myelomonocytic leukemia (AML-M4) is a subtype of AML with malignant proliferation of the common precursor of the myeloid and monocytic cells. AML-M4 is rare disease in dogs [8] . To our knowledge, there have so far been only a few reports associated with this disease in dogs [1] [2] [3] . The hematological characteristics and the clinical courses of the disease are therefore unclear. This paper describes one case of AML-M4 with the extradural lesion.
A two-year-old intact male mixed-breed dog was evaluated because of lethargy, anorexia, and trachelodynia. All physical examination findings were within normal limits with the exception of neck pain. Neurological examination revealed no abnormalities. However the dog showed acute tetraparesis 2 days after first examination. Conscious proprioception was absent bilaterally in the thoracic limbs and decreased bilaterally in the pelvic limbs. Spinal reflexes were increased in the thoracic and pelvic limbs. Deep pain perception retained. No cranial nerve deficits were detected. These findings were suggestive of disturbances of C1-C5.
At first examination, the hematologic analysis revealed marked leukocytosis (40,900 cells/μl), marked thrombocytopenia (12,000 cells/μl), and moderate anemia (3.86×10 6 cells/μl). Serum biochemical analysis revealed elevated liver enzymes (alanine aminotransferase >1,000 U/l, alkaline phosphatase 437 U/l) and C-reactive protein concentration (10 mg/dl).
In blood smears stained with Wright-Giemsa, an increased number of monocytic cells including promonocytes and blast cells (5,849 cells/μl) were found. The blast cells had two characteristics. One had a high nuclear cytoplasmic ratio with strongly basophilic cytoplasm and finely granulated nuclear chromatin. Another had slightly basophilic large cytoplasm with fine nuclear chromatin and characteristics of monocytic cells such as double structures of the cytoplasm, and the pseudopod-like projection.
To identify causes of the neurologic and hematologic abnormalities, myelographic examination and bone marrow aspiration were performed under general anesthesia on day 3 after first examination. Myelographic examination revealed an extradural compression of the spinal cord at C3 and C4 (Fig. 1) . The bone marrow smears were stained with Wright-Giemsa, and more than 500 cells counted ( Table 1) . The bone marrow was hyperplastic, and the numbers of megakaryocytes and erythroid cells were severely decreased. The granulocytic cells in stages later than metamyelocytes were also decreased. The proportion of the blast and monocytic cells including promonocytes was high (20.7% of all nucleated cells [ANC] and 53.2% of nonerythroid cells [NEC], respectively; Fig. 2A ). The granulocytic cells accounted for 25.7% of NEC. To clarify the characteristics of these cells, peroxidase, alpha-naphthol butyrate esterase (α-NBE), and naphthol-AS-D chloroacetate esterase (N-ASDCAE) stains were performed. The blast cells showed various reactions from negative to strongly positive for peroxidase staining (Fig. 2B) . The monocytic cells and some of the blast cells were positive for α-NBE staining, and these reactions were inhibited by sodium fluoride (NaF). Some of other blast cells were positive for N-ASDCAE. These results indicate that the blast cells were myeloblasts and monoblasts (Fig. 2C) . The proportion of the blast cells was more than 20% and the monocytic and granulocytic cells each comprised more than 20% of NEC. Based on these findings, this dog was diagnosed with acute myelomonocytic leukemia (AML-M4), and the neurological abnormalities were suspected to result from the mass lesion around the spinal cord formed by AML-M4.
Multi-drug chemotherapy protocol including vincristine, L-asparaginase, and prednisolone was started on day 9. Vincristine (0.6 mg/m 2 , IV) was administered on day 9, 19, 29, 43, and 50. L-asparaginase (10,000 U/m 2 , IM) was administered on day 11 and 51. Prednisolone (1 mg/kg, SC) was administered once daily. As a result, the neurological abnormalities improved gradually and the dog regained the ability to walk on day 29. The significant improvement of the leukocytosis, anemia, and thrombocytopenia was also achieved. However, on day 56, the dog became tetraparesis again. Cytarabine (100 mg/m 2 , SC) was then administered on day 57, 58, and 59. The dog showed no response to administration of cytarabine, and the performance status became worse with a relapse of severe leukocytosis with marked increase of monocytic and blast cells. The neurological abnormalities also became worse. On day 60, the dog had astasia and dyspnea suspected to be caused by dysmobility of respiratory muscles, therefore the dog was euthanized by the owner's request.
Postmortem myelographic examination revealed the extradural compression of the spinal cord at C2, C3, C4, and C5. During necropsy, hyperplasia of fatty-like tissue was found in the extradural space around the cervical spinal cord. Microscopic examination of this tissue revealed diffuse proliferation of the neoplastic cells (Fig. 3A) . These cells were irregularly round with oval to irregularly round nuclei, clear to tuberous chromatin, and distinct large nucleoli. Some of these cells had folded or horseshoe-shaped nuclei (Fig. 3B) . Immunostaining revealed that they were negative for CD3 and CD79a and some of them were positive for lysozome (Fig. 3C ): these characteristics indicate that they are monocytic cells. Cytochemical staining indicated that these cells were positive for α-NBE and N-ASD-CAE: these characteristics indicate that they are monocytic or myeloid cells. According to these findings, the infiltrative lesion in the extradural space was caused by AML-M4. The liver and the spleen were also infiltrated by the similar cells.
Criteria for diagnosing and classifying AML subtypes were revised many times. The proportion of the blast cells necessary for the diagnosis of AML was changed to 20% of ANC in the bone marrow in the new World Health Organization (WHO) classification from 30% in the French-American-British (FAB) classification [4, 6] . The reason comes from the fact that there is little difference between the prognosis of the patient with blast cells comprising over 20% but less than 30% of ANC in the bone marrow classified into refractory anemia with excess blast cells in transformation (RAEB-t) in myelodysplastic syndrome (MDS) in the FAB classification and that of the patient with blast cells comprising over 30% of ANC in the bone marrow classified into AML in this classification. The fraction of the blast cells in this case was 20.7% of ANC and therefore this case was classified into AML in accordance with the new WHO classification. In addition, the monocytic and granulocytic cells each comprised more than 20% of NEC, therefore this case was diagnosed as AML-M4.
This case showed the neurological signs such as tetraparesis, and the infiltrative lesion around the cervical spinal cord was confirmed by necropsy. In humans, monocytic leukemia including this subtype is regarded as subtypes that infiltrate extramedullary space at higher frequency than other subtypes [7] . In dogs, there are some reports about acute myelomonocytic leukemia with extramedullary infiltration [1, 2] . In the future, it is important to recognize that acute myelomonocytic and monocytic leukemia with extramedullary infiltration can be encountered in dogs.
In general, the treatment of canine acute myeloid leukemia by chemotherapy has not been successful; the prognosis is poor and many cases have died within a few months [1] [2] [3] 5] . In this case, vincristine was used as a chemotherapeutic agent. As a result, the dog responded well to this agent. One report also described that a dog finally diagnosed as AML-M4 had showed relatively good response to a treatment regimen mainly used vincristine based on a tentative diagnosis of ALL rather than AML-M4 [3] . However, this case relapsed within one month, and therefore, further studies are required to develop a more effective therapeutic regimen for AML in dogs.
